These results show that GPX1 provides the major part of hydroperoxide-reducing GPX activity in MEF cells, while GPX2 effects cannot be properly studied in this cellular system, indicating the limitations of available cellular systems to study both GPX enzymes beyond cancer cell lines. The gene discussed is GPX2; the disease is cancer.